InsiderSignal.AI

InsiderSignal.ai

RLMD - Relmada Therapeutics, Inc.

Insider Purchase by Ence Chuck (CAO, COO)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

3 months ago, Ence Chuck, serving as CAO, COO at Relmada Therapeutics, Inc. (RLMD), purchased 136,000 shares at $2.20 per share, for a total transaction value of $299,200.00. Following this transaction, Ence Chuck now holds 403,931 shares of RLMD.

This purchase represents a 51.00% increase in Ence Chuck's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, November 5, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, November 6, 2025, 1 day after the trade was made.

Relmada Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Ence Chuck

CAO, COO

Charles S. Ence is the Chief Accounting and Compliance Officer (CAO) and Chief Operating Officer (COO) at Relmada Therapeutics, Inc. (RLMD), a clinical-stage biotechnology company focused on CNS disorders.[[1]](https://www.relmada.com/company)[[2]](https://lifesciencehistory.com/companies/relmada-therapeutics-inc/)[[3]](https://www.gurufocus.com/insider/108233/chuck-ence) He joined Relmada in 2020, transitioning from CFO to his current CAO role while expanding financial operations.[[1]](https://www.relmada.com/company)[[4]](https://quotes.sina.com.cn/usstock/hq/officers.php?s=rlmd)[[7]](https://bioadvance.com/wp-content/uploads/2020-01-10_Relmada_Therapeutics_Strengthens_Financial_206.pdf) Ence brings extensive finance experience, including serving as CFO and Corporate Controller at New Age Beverages Corp. from 2003 to 2019, where he drove expansion to 46 U.S. states and 10 countries, ensured profitability, and led a NASDAQ uplisting.[[1]](https://www.relmada.com/company) Previously, he held senior roles at Quantum Corp. as Planning Manager and Director of Finance, Director of Finance and Investor Relations at On Command Corp., and spent 12 years at PepsiCo in financial analysis and controllership.[[1]](https://www.relmada.com/company) He holds a Bachelor of Arts in Business Administration and Accounting from Southern Utah University (1984) and an MBA in Finance from Arizona State University (1985).[[1]](https://www.relmada.com/company)

View full insider profile →

Trade Price

$2.20

Quantity

136,000

Total Value

$299,200.00

Shares Owned

403,931

Trade Date

Wednesday, November 5, 2025

109 days ago

SEC Filing Date

Thursday, November 6, 2025

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Relmada Therapeutics, Inc.

Company Overview

No company information available
View news mentioning RLMD

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/1087922

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime